Assessing the predictability of IDH mutation and MGMT methylation status in glioma patients using relaxation-compensated multipool CEST MRI at 7.0 T
AbstractBackground. Early identification of prognostic superior characteristics in glioma patients such as isocitrate dehydrogenase (IDH) mutation and O6-methy
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
[2018]
|
| In: |
Neuro-Oncology
Year: 2018, Volume: 20, Issue: 12, Pages: 1661-1671 |
| ISSN: | 1523-5866 |
| DOI: | 10.1093/neuonc/noy073 |
| Online Access: | Verlag, Volltext: https://doi.org/10.1093/neuonc/noy073 Verlag, Volltext: https://academic.oup.com/neuro-oncology/article/20/12/1661/4992691 |
| Author Notes: | Daniel Paech, Johannes Windschuh, Johanna Oberhollenzer, Constantin Dreher, Felix Sahm, Jan-Eric Meissner, Steffen Goerke, Patrick Schuenke, Moritz Zaiss, Sebastian Regnery, Sebastian Bickelhaupt, Philipp Bäumer, Martin Bendszus, Wolfgang Wick, Andreas Unterberg, Peter Bachert, Mark Edward Ladd, Heinz-Peter Schlemmer, Alexander Radbruch |
| Summary: | AbstractBackground. Early identification of prognostic superior characteristics in glioma patients such as isocitrate dehydrogenase (IDH) mutation and O6-methy |
|---|---|
| Item Description: | Advance access date 4 May 2018 Gesehen am 06.03.2020 |
| Physical Description: | Online Resource |
| ISSN: | 1523-5866 |
| DOI: | 10.1093/neuonc/noy073 |